Imatinib Mesylate
NDC 0904-6621, Imatinib Mesylate, tablet, film coated, from Major Pharmaceuticals.
- Product NDC
- 0904-6621
- Status
- Listed
- Labeler
- Major Pharmaceuticals
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079179
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0904-6621 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMATINIB MESYLATE400 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0904-6621-04 | 00904662104 | 30 BLISTER PACK in 1 CARTON (0904-6621-04) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7c037022-7fc8-4b6e-9db3-427206c572b4NADAC price for package 00904662104
GET /v1/drugs/nadac/00904662104
Use it
Look up 0904-6621 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0904-6621 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0904-6621. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.